๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effects of denosumab and alendronate at the ultradistal radius in postmenopausal women with low bone mass

โœ Scribed by E. Seeman; T. Thomas; S.K. Boyd; S. Boutroy; E. Shane; D.A. Hanley; C. Bogado; A.M. Cheung; S. Majumdar; D. Sellmeyer; A. Kearns; P.D. Delmas; M. Fan; C. Libanati; J. Zanchetta


Book ID
116321645
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
50 KB
Volume
44
Category
Article
ISSN
8756-3282

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Comparative effects of raloxifene and al
โœ Robert R. Recker; David Kendler; Christopher P. Recknor; Theodore W. Rooney; E. ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 265 KB

The double-blind, randomized raloxifene alendronate comparison trial was the first study designed to compare two osteoporosis therapies head-to-head for fracture risk reduction. The original protocol planned to treat 3000 postmenopausal women with alendronate 10 mg/day (ALN) or raloxifene 60 mg/day